Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000733060-19-000013
Filing Date
2019-02-21
Accepted
2019-02-21 08:33:35
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT dbvtech2018.htm SC 13G/A 73817
  Complete submission text file 0000733060-19-000013.txt   75570
Mailing Address 91-93 BOULEVARD PASTEUR PARIS I0 75015
Business Address 91-93 BOULEVARD PASTEUR PARIS I0 75015 33 1 43 23 30 30
Amundi (Filed by) CIK: 0001330387 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120
Business Address 177-181 AVENUE PIERRE BROSSOLETTE MONTROUGE I0 92120 33(0)155427878
DBV Technologies S.A. (Subject) CIK: 0001613780 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88701 | Film No.: 19620581
SIC: 2836 Biological Products, (No Diagnostic Substances)